Industries > Pharma > Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029

Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029

Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Roche, Siemens AG, Sysmex, Other Companies

PUBLISHED: 14 May 2019
PAGES: 204
PRODUCT CODE: PHA0420
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The global in vitro diagnostics (IVD) market is estimated to have reached $69.2bn in 2018. The largest sector of the IVD market in 2018 was point of care diagnostics segment, generating sales of $19.4bn in 2018, which accounted for 28.0% of overall IVD sales.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 204-page report you will receive 180 charts– all unavailable elsewhere.

The 204-page report provides clear detailed insight into the leading in vitro diagnostics (IVD) companies. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• In Vitro Diagnostics (IVD) revenues in 2017 and 2018 by Class:
• Point-of-Care
• Clinical Chemistry
• Immunochemistry
• Hematology
• Microbiology
• Genetic Testing
• Others

• In Vitro Diagnostics (IVD) revenue forecast for 2019, 2024 and 2029 by Class:
• Point-of-Care
• Clinical Chemistry
• Immunochemistry
• Hematology
• Microbiology
• Genetic Testing
• Others

• This report profiles and discusses the selected leading in vitro diagnostics (IVD) companies:
• Abbott Laboratories
• Arkray, Inc.
• Becton, Dickinson and Company (BD)
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Dako (Agilent Technologies)
• Danaher Corporation
• Genomic Health
• Laboratory Corporation of America (LabCorp)
• MDxHealth
• Myriad Genetics
• QIAGEN
• Roche
• Siemens AG
• Sysmex Corporation
• Thermo Fisher Scientific
• Other companies

Top In Vitro Diagnostics (IVD) Companies 2019-2029

• This report discusses sales and recent performance analysis, key products, strengths and challenges, historical revenues, revenue forecast, market share forecast, mergers and acquisition (M&A) activity, strategic collaborations

• Analysis of factors that drive and restrain the in vitro diagnostics (IVD) market.
• Key Questions Answered by this Report:
• Who are the leading IVD manufacturers?
• What factors are driving and restraining growth for the leading IVD manufacturers?
• How have the leading IVD manufacturers performed financially in recent years?
• Which IVD manufacturers will experience revenue growth over the coming years?
• What are the strength and weakness of the leading IVD manufacturers?
• What strategies have IVD manufacturers been implementing for sales growth in recent years?

Visiongain’s study is intended for anyone requiring commercial analyses for the leading in vitro diagnostics (IVD) companies. You find data, trends and predictions.

Buy our report today Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Market Analysis : Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Roche, Siemens AG, Sysmex, Other Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Medical Devices Leader Series: Top In Vitro Diagnostics (IVD) Companies 2019-2029


Latest Pharma news

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ

Visiongain Publishes Medical Device Contract Manufacturing Market Report 2022-2032

The medical device contract manufacturing market was valued at US$69.22 billion in 2021 and is projected to grow at a CAGR of 12.9% during the forecast period 2022-2032.

13 September 2022

READ